Cargando…
Lai C, Ranpura V, Wu C, et al. Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. Blood Adv. 2019;3(7):980-983.
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560351/ https://www.ncbi.nlm.nih.gov/pubmed/31160296 http://dx.doi.org/10.1182/bloodadvances.2019000319 |
| _version_ | 1783425952606322688 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6560351 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65603512019-06-12 Lai C, Ranpura V, Wu C, et al. Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. Blood Adv. 2019;3(7):980-983. Blood Adv Erratum American Society of Hematology 2019-06-03 /pmc/articles/PMC6560351/ /pubmed/31160296 http://dx.doi.org/10.1182/bloodadvances.2019000319 Text en © 2019 by The American Society of Hematology |
| spellingShingle | Erratum Lai C, Ranpura V, Wu C, et al. Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. Blood Adv. 2019;3(7):980-983. |
| title | Lai C, Ranpura V, Wu C, et al. Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. Blood Adv. 2019;3(7):980-983. |
| title_full | Lai C, Ranpura V, Wu C, et al. Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. Blood Adv. 2019;3(7):980-983. |
| title_fullStr | Lai C, Ranpura V, Wu C, et al. Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. Blood Adv. 2019;3(7):980-983. |
| title_full_unstemmed | Lai C, Ranpura V, Wu C, et al. Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. Blood Adv. 2019;3(7):980-983. |
| title_short | Lai C, Ranpura V, Wu C, et al. Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. Blood Adv. 2019;3(7):980-983. |
| title_sort | lai c, ranpura v, wu c, et al. long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. blood adv. 2019;3(7):980-983. |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560351/ https://www.ncbi.nlm.nih.gov/pubmed/31160296 http://dx.doi.org/10.1182/bloodadvances.2019000319 |